Early research (Phase 1)Ended earlyNCT06158958
What this trial is testing
Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
Who this might be right for
Solid Tumors
AbbVie 27